Conversely, Rab25 expression correlates with decreased survival and increased aggressiveness of ovarian cancer (Cheng et al., 2004), and enhanced invasive migration of ovarian cancer cells in vitro (Caswell et al., 2007). Here, RAB25 is linked to ovarian carcinoma.